A detailed history of Mid Atlantic Capital Management, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Mid Atlantic Capital Management, Inc. holds 67 shares of DGX stock, worth $9,185. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67
Holding current value
$9,185
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$137.09 - $137.09 $9,185 - $9,185
67 New
67 $10.4 Million
Q1 2024

Nov 12, 2024

SELL
$123.78 - $142.11 $1,856 - $2,131
-15 Reduced 17.44%
71 $9.45 Million
Q4 2023

Nov 12, 2024

BUY
$120.62 - $141.12 $2,291 - $2,681
19 Added 28.36%
86 $11.9 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Mid Atlantic Capital Management, Inc. Portfolio

Follow Mid Atlantic Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid Atlantic Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid Atlantic Capital Management, Inc. with notifications on news.